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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
Drug nephrotoxicity  
in the ICU
In this timely review, Perazella examines the 
problems associated with the use of poten­
tially nephrotoxic drugs in patients in the 
intensive care unit (ICU). These patients 
are exposed to numerous pharmaceutical 
agents, many of which have narrow thera­
peutic windows and toxic potential. 
Comorbid conditions, altered drug phar­
macokinetics, and drug–drug interac­
tions further enhance the risk of both drug 
overdosing and underdosing and adverse 
medication effects. Underdosing is compli­
cated by reduced efficacy, whereas overdos­
ing results in various end­organ toxicities, 
including acute kidney injury (AKI), a 
common problem in the ICU. Potentially 
nephrotoxic medications contribute signifi­
cantly to the development of AKI. In view 
of these issues, the review provides guide­
lines to clinicians caring for these patients 
for the appropriate drug dosing based on 
the knowledge of altered pharmacokinet­
ics, vigilant monitoring of drug efficacy and 
toxicity, recognition of drugs with nephro­
toxic potential, and early identification of 
drug­induced AKI. See page 1172.
Hemodialysis mortality 
and antibodies against 
b-glycoprotein
Cardiovascular complications are the most 
common complications in patients on 
dialysis. Antibodies against b­glycoprotein 
I may play a role in antiphospholipid syn­
drome and stroke and are involved in ath­
erosclerosis. Furthermore, such antibodies 
of the IgG class are elevated in patients with 
chronic kidney disease. Serrano et al. there­
fore evaluated the presence of anti­cardi­
olipin and anti­b­glycoprotein I antibodies 
specifically of the IgA subclass together with 
other vascular risk factors in a cohort of 124 
hemodialysis patients prospectively followed 
for 2 years. Forty­one patients (33%) were 
positive for IgA anti­b­glycoprotein I. At 24 
months, overall and cardiovascular mor­
tality and thrombotic events were all sig­
nificantly higher in the patients with high 
anti­b­glycoprotein I antibodies. Multivari­
ate analysis using Cox regression modeling 
found that age, hypoalbuminemia, use of 
dialysis catheters, and IgA b­glycoprotein 
I antibodies were independent risk factors 
for death. The authors suggest that the asso­
ciation of elevated IgA antibodies against 
b­glycoprotein I with worse outcome in 
hemodialysis patients may indicate a poten­
tial pathogenetic role for these antibodies, 
which could serve as an additional risk bio­
marker in this group. See page 1239.
Ephrin and glomerular 
repair
Ephrins play a significant role in organ 
homeostasis and are expressed in the kid­
ney. Recently, ephrinB1, a ligand of the 
EphB family of receptor tyrosine kinases, 
has emerged as yet another protein located 
at the glomerular slit membrane. Wnuk et 
al. explored the potential role of ephrinB 
signaling in the recovery from experimen­
tal glomerular Thy1.1 nephritis in rats. The 
ephrinBs and their receptor EphB4 were 
expressed in normal podocytes and were 
upregulated—and EphB4 was phosphory­
lated, indicating activation—during Thy1.1 
nephritis. While treatment with an inhibi­
tor of EphB4 phosphorylation did not cause 
glomerular changes in controls, it induced 
glomerular microaneurysms, with podocyte 
damage and loss, in nephritic rats. Prolonged 
treatment with the inhibitor increased albu­
minuria and slowed mesangial recovery. 
Most interestingly, the ephrin inhibitor 
decreased capillary repair by intussuscep­
tive angiogenesis, indicating a previously 
unrecognized role of podocytes in regulating 
intussusceptive capillary generation. Thus, 
ephrinB signaling may contribute to podo­
cyte repair, which, in turn, appears to influ­
ence capillary and mesangial regeneration. 
These observations indicate yet another way 
of cross­talk between podocytes, mesangial 
cells, and endothelial cells in glomerular 
capillaries, which may be of special impor­
tance in recovery from glomerular injury. 
See page 1212.
